- Home
- / MYND Life Sciences
MYND Life Sciences
Stock Price
$0
2024-10-29
Market Capitalization
$956.3 K
2024-10-29
MYND Life Sciences Summary
Company Summary
- Overview
- MYND Life Sciences is a life science company that develops drugs. It offers clinical trials, postpartum depression, medical diagnostics, imaging, and other services.
- Type
- Public
- Status
- Active
- Founded
- 2020
- Cybersecurity rating
Table of Contents
MYND Life Sciences Financials
Summary Financials
- Net income (Q3, 2024)
- ($C380.0K)
- EBIT (Q3, 2024)
- ($C343.0K)
- Enterprise value
- $4.0M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026